Search tips
Search criteria 


Curr Opin Microbiol. 2009 February; 12(1-3): 101–109.
PMCID: PMC2697328

The effector repertoire of enteropathogenic E. coli: ganging up on the host cell


Diarrhoeal disease caused by enteropathogenic E. coli (EPEC) is dependent on a delivery system that injects numerous bacterial ‘effector’ proteins directly into host cells. The best-described EPEC effectors are encoded together on the locus of enterocyte effacement (LEE) pathogenicity island and display high levels of multifunctionality and cooperativity within the host cell. More recently, effectors encoded outside the LEE (non-LEE effectors) have been discovered and their functions are beginning to be uncovered. The recent completion of the EPEC genome sequence suggests its effector repertoire consists of at least 21 effector proteins. Here, we describe the genomic location of effectors and discuss recent advances made on effector cellular function as well as their role in the infection process.


Enteropathogenic E. coli (EPEC) is a human pathogen of the small intestine that causes severe watery diarrhoea, particularly among infants in developing countries [1]. EPEC is a member of a closely related family of pathogens that induce characteristic attaching and effacing (A/E) lesions on intestinal epithelial cells in humans (EPEC and EHEC — enterohaemorrhagic E. coli), ruminants (EHEC) and small animals including mice (Citrobacter rodentium) [2]. Hallmarks of EPEC disease are loss (effacement) of absorptive microvilli, induction of actin-rich pedestals underneath adherent bacteria, rapid watery diarrhoea, inhibition of nutrient/water transporter function, mitochondrial dysfunction, a weak inflammatory response and tight junction (TJ) disruption (see [1,3]). Upon initial contact with intestinal enterocytes, mediated in part by the bundle forming pilus (BFP), EPEC rapidly cause the effacement of microvilli and induce localised actin polymerisation that gives rise to a pedestal beneath the bacteria, to which the bacteria intimately attach. Mitochondrial dysfunction and disruption of nutrient transporters are also early events, whilst the disruption of TJ is only apparent later on during the infection process. EPEC is considered a non-invasive pathogen and relies upon on a type three secretion system (T3SS) to deliver effector proteins directly into host cells which subvert a myriad of host cellular functions, ultimately leading to disease [3]. The first EPEC effectors to be discovered are all encoded on a large genomic pathogenicity island called the locus of enterocyte effacement (LEE), which also carries EPEC's only T3SS, with seven LEE effectors identified to date. More recently, effectors encoded outside the LEE region have been found in all A/E pathogens [4,5] which utilise the LEE T3SS for delivery into host cells and recent functional studies on these ‘non-LEE’ effectors have started to ascribe cellular functions to these proteins. The completion of the genome sequence of the prototypical EPEC strain E2348/69 (herein termed EPEC; has confirmed the presence (or absence) of many non-LEE effector genes [6•].

EPEC also possess a type two secretion system (T2SS), although little is known about its role in virulence or its protein substrates [6•], and a type five secretion system (T5SS) which includes the enterotoxin EspC and other putative autotransporters [7,8••]. Interestingly, the entry of EspC into the host cells has been shown to be dependent on T3SS [8••] and it is likely that other autotransporters may also depend on the T3SS. In this review we will focus on the repertoire of type three secreted EPEC effector proteins and the important advances made on effector functions over the past few years. We redirect the reader to other reviews for information on other virulence factors and general mechanisms of EPEC pathogenesis [1,3,7].

EPEC effector nomenclature

The naming of EPEC effectors has been based on three approaches and may be somewhat confusing to the lay reader. Traditionally, the term ‘Esp-’ was used to denote EPEC secreted protein and now includes the LEE effectors EspB/F/G/H. However, EspA and EspD, which have not been reported to possess effector activity, and the autotransporter EspC, also fall into this category, making effector designation a little ambiguous. A different approach was to name effectors to reflect their reported function, thus the LEE effectors Translocated Intimin receptor (Tir) and Mitochondrial-associated protein (Map) fall into this group. Finally, the term non-LEE encoded (Nle-) was coined by Deng et al. following their discovery of several non-LEE effectors in Citrobacter [4]. However, this designation has not been adopted for all non-LEE effectors — such as the non-LEE located EspG2/Orf3 [9], EspI/NleA [10], cycle inhibiting factor (Cif) [11] and a set of recently discovered non-LEE effectors in EHEC, which have all been given the prefix ‘Esp-’ [5], of which EspJ and EspL are encoded in EPEC (Table 1).

Table 1
The effector repertoire of EPEC 2348/69 and known functional characteristics of effector proteins.

The LEE effectors — highly interdependent and multifunctional

Historically, the LEE effectors were the first to be identified in EPEC and to date a total of seven LEE-encoded proteins delivered into the host cell have been discovered, namely Tir, Map, EspF, EspG, EspZ (previously SepZ), EspH and EspB (which is also a translocator and essential for the delivery of effectors into the host cell) (see Table 1 and [3]). Also present on the LEE is the outer membrane protein Intimin which, whilst not delivered into host cells, causes numerous host cell responses directly through its bacterial-encoded receptor Tir or through various host cell receptors [1,3]. All the LEE effectors, except EspZ [12], have proven deleterious effects on the host cell (Table 1 and see [3]) and it is likely that EspZ has important effector functions as it is delivered early in the infection process and at similarly high levels as the essential virulence determinant, Tir [13]. The importance of the LEE effectors in the disease process is unclear but animal infections using Citrobacter and EHEC (as EPEC lacks a suitable animal model) indicate that Tir is essential, linked to its role in bacterial attachment, whilst the other LEE effectors have a smaller but additive contribution to virulence [2,10,14,15].

The functions of the LEE effectors are highly varied and Table 1 gives an up-to-date and comprehensive list of reported effector functions. An emerging theme for the LEE effectors, consistent with findings in other T3SS-pathogens, is their multiple and overlapping functions (termed functional redundancy) and their interdependence and cooperativity in subverting host cell activities (Table 1 and Figure 1). For example, Map and EspF synergise [16] whilst EspG and EspG2 function redundantly [17] in the disruption of epithelial TJ, with the Map/EspF TJ-disrupting activity proven in vivo [14,18]. Tir is essential for actin-pedestal formation following binding to Intimin but is also involved in TJ disruption, independent and dependent of Intimin (Dean and Kenny, unpublished). Tir also downregulates Map-induced filopodia formation (see [3]) and coordinates with EspF, Intimin and Map to cause microvilli effacement [19•]. Indeed, Knutton and colleagues have also reported overlapping roles for LEE effectors in microvilli effacement ex vivo, using human intestinal material [20]. In addition, Map and EspF both target mitochondria to alter organelle shape and cause dysfunction — an activity that occurs in vivo and proven to be important in disease [14,15]. Such effector cooperativity appears to be just the ‘tip of the iceberg’ as a systematic genetic study in which the LEE effectors were deleted in many different combinations eludes to an unprecedented level of functional cooperativity between effectors (Kenny et al., unpublished). To this end, all the major reported hallmarks of EPEC disease can be attributed to the cooperative efforts of the LEE effectors (Figure 1).

Figure 1
The complexity of EPEC effector function. The multifunctional and overlapping properties of the EPEC effectors are depicted here by grouping effector functions together. Three effectors have anti-phagocytic activities (shown here using the phagocytic-like ...

In addition to their cooperative nature, the LEE effectors are strikingly multifunctional (Table 1) binding a large number of eukaryotic proteins and targeting various host cell compartments (Table 1 and Figure 1). This is best exemplified by EspF which localises to multiple cellular compartments (including cytoplasm, mitochondria, apical and lateral membranes) and interacts with at least 12 reported host proteins, with its delivery linked to mitochondrial dysfunction, microvilli effacement, TJ disruption, apoptosis, epithelial transporter inhibition, anti-phagocytosis, membrane remodelling and actin-pedestal maturation [15,16,18–22,26,51–53]. Like other LEE effectors, the modular construction of EspF facilitates its multifunctional behaviour (Figure 2), with specific motifs inducing distinct cellular responses, such as an N-terminal mitochondrial targeting sequence (MTS) linked to mitochondria dysfunction and apoptosis [15,21], whilst proline-rich repeats, that include src homology 3 (SH3)-binding domains, recruit sorting nexin 9 (SNX9) causing membrane remodelling ([22]; Table 1 and Figure 2). EspF, like its EHEC homologues EspF and EspFU/Tccp, recruits N-WASP (a key regulator of actin polymerisation), with studies on EspFU revealing it specifically activates N-WASP by mimicking an internal regulatory element [23,24]. Finally, although EspF plays an essential role in anti-phagocytosis, EspB–myosin interaction has recently been reported to inhibit both phagocytosis and microvilli effacement [25•]. However, as both of these bacterial processes can occur with EspB/EspF-positive but not EspB-positive/EspF-negative strains [19•,26]; this suggests that EspB is neither solely responsible nor sufficient.

Figure 2
The modular nature of multifunctional LEE effector proteins. Tir, Map and EspF are the best-studied EPEC effectors and have been implicated in subverting multiple cellular processes. These proteins possess many eukaryotic-like motifs with many being assigned ...

Effector multifunctionality is further demonstrated by Map and Tir which like EspF, possess motifs that mediate a broad array of functions ([3]; Table 1 and Figure 2). All of Tir's reported activities depend on its extracellular domain (Figure 2) binding to Intimin, following Tir insertion into the host plasma membrane. Tir's N-terminal and C-terminal domains remain intracellular and interact with numerous signalling, adapter and cytoskeletal proteins with Tir function dependent on its phosphorylation sites, a GTPase activating protein (GAP)-like motif and a polyproline region (Figure 2) [27–29]. Interestingly, although tyrosine phosphorylation of Tir is essential for actin-pedestal formation in immortalised cell lines, human biopsy material has revealed that this crucial event is independent of tyrosine phosphorylation ex vivo, suggesting care should be taken when using cell lines to elucidate effector function [30••]. Map on the other hand is reported to mimic the active form of Cdc42 — a small GTPase — to induce filopodia formation [31], in contrast to an earlier report demonstrating a dependence on Cdc-42 itself [32]. The filopodia-inducing functions of Map depend on an invariant WxxxE motif and a C-terminal class 1 PDZ-binding domain that binds Ezrin-binding protein 50 [31,33] to presumably direct or retain Map to the plasma membrane. Whether or not Map is a Cdc42 mimic is open to debate as other effectors of the WxxxE family appear to require GTPases to elicit their cellular responses [32,34••] and the controversy surrounding the WxxxE effector family has been eloquently discussed in a recent review which provides a compelling argument to suggest these effectors may not be GTPase mimics after all [34••]. Finally, Map possesses an N-terminal MTS and targets the mitochondria where it is imported via the classical TOM/Hsp70 import system and causes mitochondrial dysfunction [35] (see Figures 1 and 2).

EPEC non-LEE effectors and non-LEE pathogenicity islands

Whilst mining the EHEC (O157:H7 Sakai strain) genome sequence with over 200 known/predicted T3SS-dependent effector proteins, Pallen and colleagues identified 49 putative effectors [5]. At least 39 of these predicted proteins, of which many are homologues, were confirmed as secreted effectors in EHEC and include NleA-H (noting 12 NleG homologues) and newly described EspJ-O, EspR and EspV-Y effectors [5]. The recent completion of the EPEC genome sequence (strain E2348/69) enabled a similar ‘effector mining’ approach using an expanded list of over 400 known/predicted effector sequences and identified only 21 putative effectors (Dean and Kenny, unpublished; Table 1 and Figure 3). Thus, as recently reported [6•], EPEC appears to have a much smaller non-LEE effector repertoire than EHEC, encoding NleA-H (two homologues of B, E, H and only 1 of NleG), EspJ and EspL2, Orf3 (EspG2; which is the only EPEC effector so far identified that is not present in EHEC) and pseudogenes for NleH, EspO, NleB, EspL and Cif (Table 1 and Figure 3). Thus, whilst the LEE effector repertoire is well conserved, the set of non-LEE effectors is apparently flexible as EPEC strains B171-8 and E22 (rabbit-EPEC) possess 28 and 40 effectors, respectively, compared to 21 for the prototypical strain [6•].

Figure 3
The six identified non-LEE effector encoding pathogenicity islands of EPEC E2348/69. Predicted effector genes were identified by mining the EPEC genome using over 400 known/predicted effector sequences. The identified effectors and genomic islands support ...

The non-LEE effector genes are clustered in six pathogenicity islands (Figure 3) scattered throughout the genome, usually with a low G + C% content in regions corresponding to effector genes. Interestingly, the non-LEE effector genes are surrounded by phage-related and/or transposase-like genes implying that, like most pathogenicity islands, they were acquired through horizontal acquisition [6•]. Whilst EPEC E2348/69 carries at least 21 effector-encoding genes, it is not known whether they are all expressed but undoubtedly other effectors remain to be identified. Indeed, there are many hypothetical genes in the non-LEE islands that are likely candidates as effectors because of their low %GC content and close proximity to known effector genes (Figure 3).

Because of the more recent discovery of non-LEE effectors, relatively little is known about their cellular function (summarised in Table 1), but NleA is reported to inhibit protein secretion [36•], EspJ inhibits phagocytosis [37], whilst NleE [38] and NleH [39] activate innate immune responses. Studies with the mouse model suggest that EspJ, NleB, NleE, NleF and NleH play a role in colonisation and full virulence [40–43] whilst NleC and D have no detectable function [40,41]. Although NleA (also called EspI) was reported to be a key virulence factor [44], another study using the same mouse model, reported that it only contributes to full virulence — as with most other effectors [10]. Interestingly, despite NleE and NleH reportedly inducing innate immune responses, EPEC T3SS-dependent function has been demonstrated to inhibit, not activate, such responses in small intestinal cells and mouse studies [45•,46]. Importantly, the reported inhibitory mechanism was not dependent on LEE effectors, implicating non-LEE effectors in the process [45•] although a LEE effector was recently identified that inhibits NF-κB activation (Kenny et al., unpublished) — revealing yet another overlapping role for LEE and non-LEE effectors. Therefore, a discrepancy exists as NleE and NleH appear to induce inflammatory responses, whilst EPEC's overall effect on host/host cells is anti-inflammatory. It is possible that EPEC transiently induces pro-inflammatory responses but rapidly inactivates this response mechanism before the disruption of TJs, that is associated with onset of inflammatory cascades [45•]. Thus, like the activities of many other EPEC effectors, a delicate balance likely exists between pro-inflammatory and anti-inflammatory signalling mechanisms [47].


‘Multifunctional, cooperative and redundant’ are three overriding themes that describe EPEC effector behaviour and are becoming increasingly accepted for various T3SS-pathogen effectors. Interestingly, the LEE effectors appear to subvert many ‘core’ epithelial cell processes and consequently, all of the major EPEC disease-related hallmarks have been attributed to the LEE effectors, suggesting the non-LEE effectors may function mainly as accessory/efficiency factors. However, it is worth pointing out that individual non-LEE effectors are more highly conserved between A/E pathogens than LEE effectors [6•], possibly reflecting the targeting of well conserved processes, whilst LEE-effector variability may reflect different host ranges. The high level of functional interdependence between the LEE effectors possibly reflects their continued co-evolution within the LEE pathogenicity island and this sets an exciting precedent that other effectors co-inherited together may display similarly complex levels of interplay. A future challenge will be to define the contribution of all effectors in each disease process by identifying the effector domains and motifs responsible. Only then the contribution of the particular effector function to the disease process can be assessed in animal models. Nonetheless the expanded repertoire of effectors provides fascinating opportunities to understand how pathogens subvert cellular processes and increase our understanding of vital eukaryotic processes.

References and recommended reading

Papers of particular interest, published within the period of review, have been highlighted as:

  • • of special interest
  • •• of outstanding interest


We apologise in advance to the authors of the published work that is not included in this review because of space constraints. Work within our laboratory is funded by the Wellcome Trust.


1. Chen H.D., Frankel G. Enteropathogenic Escherichia coli: unravelling pathogenesis. FEMS Microbiol Rev. 2005;29:83–98. [PubMed]
2. Mundy R., MacDonald T.T., Dougan G., Frankel G., Wiles S. Citrobacter rodentium of mice and man. Cell Microbiol. 2005;7:1697–1706. [PubMed]
3. Dean P., Maresca M., Kenny B. EPEC's weapons of mass subversion. Curr Opin Microbiol. 2005;8:28–34. [PubMed]
4. Deng W., Puente J.L., Gruenheid S., Li Y., Vallance B.A., Vazquez A., Barba J., Ibarra J.A., O’Donnell P., Metalnikov P. Dissecting virulence: systematic and functional analyses of a pathogenicity island. Proc Natl Acad Sci U S A. 2004;101:3597–3602. [PubMed]
5. Tobe T., Beatson S.A., Taniguchi H., Abe H., Bailey C.M., Fivian A., Younis R., Matthews S., Marches O., Frankel G. An extensive repertoire of type III secretion effectors in Escherichia coli O157 and the role of lambdoid phages in their dissemination. Proc Natl Acad Sci U S A. 2006;103:14941–14946. [PubMed]
6•. Iguchi A., Thomson N.R., Ogura Y., Saunders D., Ooka T., Henderson I.R., Harris D., Asadulghani M., Kurokawa K., Dean P. The complete genome sequence and comparative genome analysis of enteropathogenic E. coli O127:H6 strain E2348/69. J Bacteriol. 2009;191:347–354. [PMC free article] [PubMed]The published EPEC genome sequence revealed the prototypical EPEC strain appears to have a comparatively small repertoire of type three secreted effectors in addition to a host of other virulence factors. This paper is of particular interest given that most functional studies performed on A/E pathogen effectors have used this prototypical strain.
7. Spears K.J., Roe A.J., Gally D.L. A comparison of enteropathogenic and enterohaemorrhagic Escherichia coli pathogenesis. FEMS Microbiol Lett. 2006;255:187–202. [PubMed]
8••. Vidal J.E., Navarro-Garcia F. EspC translocation into epithelial cells by enteropathogenic Escherichia coli requires a concerted participation of type V and III secretion systems. Cell Microbiol. 2008;10:1975–1986. [PubMed]A paper with far-reaching implications as it is the first to show the cooperation between these two secretion systems with the internalisation of the EspC autotransporter protein into host cells dependent on the type three secretion system. Potentially, it opens the door to other secreted proteins, particularly autotransporters, being delivered into host cells by this mechanism.
9. Elliott S.J., Krejany E.O., Mellies J.L., Robins-Browne R.M., Sasakawa C., Kaper J.B. EspG, a novel type III system-secreted protein from enteropathogenic Escherichia coli with similarities to VirA of Shigella flexneri. Infect Immun. 2001;69:4027–4033. [PMC free article] [PubMed]
10. Mundy R., Petrovska L., Smollett K., Simpson N., Wilson R.K., Yu J., Tu X., Rosenshine I., Clare S., Dougan G. Identification of a novel Citrobacter rodentium type III secreted protein, EspI, and roles of this and other secreted proteins in infection. Infect Immun. 2004;72:2288–2302. [PMC free article] [PubMed]
11. Marches O., Ledger T.N., Boury M., Ohara M., Tu X., Goffaux F., Mainil J., Rosenshine I., Sugai M., De Rycke J. Enteropathogenic and enterohaemorrhagic Escherichia coli deliver a novel effector called Cif, which blocks cell cycle G2/M transition. Mol Microbiol. 2003;50:1553–1567. [PubMed]
12. Kanack K.J., Crawford J.A., Tatsuno I., Karmali M.A., Kaper J.B. SepZ/EspZ is secreted and translocated into HeLa cells by the enteropathogenic Escherichia coli type III secretion system. Infect Immun. 2005;73:4327–4337. [PMC free article] [PubMed]
13. Mills E., Baruch K., Charpentier X., Kobi S., Rosenshine I. Real-time analysis of effector translocation by the type III secretion system of enteropathogenic Escherichia coli. Cell Host Microbe. 2008;3:104–113. [PubMed]
14. Ma C., Wickham M.E., Guttman J.A., Deng W., Walker J., Madsen K.L., Jacobson K., Vogl W.A., Finlay B.B., Vallance B.A. Citrobacter rodentium infection causes both mitochondrial dysfunction and intestinal epithelial barrier disruption in vivo: role of mitochondrial associated protein (Map) Cell Microbiol. 2006;8:1669–1686. [PubMed]
15. Nagai T., Abe A., Sasakawa C. Targeting of enteropathogenic Escherichia coli EspF to host mitochondria is essential for bacterial pathogenesis: critical role of the 16th leucine residue in EspF. J Biol Chem. 2005;280:2998–3011. [PubMed]
16. Dean P., Kenny B. Intestinal barrier dysfunction by enteropathogenic Escherichia coli is mediated by two effector molecules and a bacterial surface protein. Mol Microbiol. 2004;54:665–675. [PubMed]
17. Tomson F.L., Viswanathan V.K., Kanack K.J., Kanteti R.P., Straub K.V., Menet M., Kaper J.B., Hecht G. Enteropathogenic Escherichia coli EspG disrupts microtubules and in conjunction with Orf3 enhances perturbation of the tight junction barrier. Mol Microbiol. 2005;56:447–464. [PubMed]
18. Guttman J.A., Li Y., Wickham M.E., Deng W., Vogl A.W., Finlay B.B. Attaching and effacing pathogen-induced tight junction disruption in vivo. Cell Microbiol. 2006;8:634–645. [PubMed]
19•. Dean P., Maresca M., Schuller S., Phillips A.D., Kenny B. Potent diarrheagenic mechanism mediated by the cooperative action of three enteropathogenic Escherichia coli-injected effector proteins. Proc Natl Acad Sci U S A. 2006;103:1876–1881. [PubMed]This paper identified the effectors that underpin EPEC-mediated of microvilli effacement and reveal effacement is the result of the concerted action of at least three effectors. In addition, a potent mechanism was uncovered to explain the rapid onset of watery diarrhoea relating to the inhibition of the major intestinal water pump SGLT-1.
20. Shaw R.K., Cleary J., Murphy M.S., Frankel G., Knutton S. Interaction of enteropathogenic Escherichia coli with human intestinal mucosa: role of effector proteins in brush border remodeling and formation of attaching and effacing lesions. Infect Immun. 2005;73:1243–1251. [PMC free article] [PubMed]
21. Nougayrede J.P., Donnenberg M.S. Enteropathogenic Escherichia coli EspF is targeted to mitochondria and is required to initiate the mitochondrial death pathway. Cell Microbiol. 2004;6:1097–1111. [PubMed]
22. Alto N.M., Weflen A.W., Rardin M.J., Yarar D., Lazar C.S., Tonikian R., Koller A., Taylor S.S., Boone C., Sidhu S.S. The type III effector EspF coordinates membrane trafficking by the spatiotemporal activation of two eukaryotic signaling pathways. J Cell Biol. 2007;178:1265–1278. [PMC free article] [PubMed]
23. Cheng H.C., Skehan B.M., Campellone K.G., Leong J.M., Rosen M.K. Structural mechanism of WASP activation by the enterohaemorrhagic E. coli effector EspF(U) Nature. 2008;454:1009–1013. [PMC free article] [PubMed]
24. Sallee N.A., Rivera G.M., Dueber J.E., Vasilescu D., Mullins R.D., Mayer B.J., Lim W.A. The pathogen protein EspF(U) hijacks actin polymerization using mimicry and multivalency. Nature. 2008;454:1005–1008. [PMC free article] [PubMed]
25•. Iizumi Y., Sagara H., Kabe Y., Azuma M., Kume K., Ogawa M., Nagai T., Gillespie P.G., Sasakawa C., Handa H. The enteropathogenic E. coli effector EspB facilitates microvillus effacing and antiphagocytosis by inhibiting myosin function. Cell Host Microbe. 2007;2:383–392. [PubMed]A controversial study which demonstrates that EspB is able to cause microvilli effacement and antiphagocytosis. This is particularly interesting given that in separate studies EspB has been shown not to cause these phenotypes (see text).
26. Quitard S., Dean P., Maresca M., Kenny B. The enteropathogenic Escherichia coli EspF effector molecule inhibits PI-3 kinase-mediated uptake independently of mitochondrial targeting. Cell Microbiol. 2006;8:972–981. [PubMed]
27. Bommarius B., Maxwell D., Swimm A., Leung S., Corbett A., Bornmann W., Kalman D. Enteropathogenic Escherichia coli Tir is an SH2/3 ligand that recruits and activates tyrosine kinases required for pedestal formation. Mol Microbiol. 2007;63:1748–1768. [PubMed]
28. Hayward R.D., Leong J.M., Koronakis V., Campellone K.G. Exploiting pathogenic Escherichia coli to model transmembrane receptor signalling. Nat Rev Microbiol. 2006;4:358–370. [PubMed]
29. Frankel G., Phillips A.D. Attaching effacing Escherichia coli and paradigms of Tir-triggered actin polymerization: getting off the pedestal. Cell Microbiol. 2008;10:549–556. [PubMed]
30••. Schuller S., Chong Y., Lewin J., Kenny B., Frankel G., Phillips A.D. Tir phosphorylation and Nck/N-WASP recruitment by enteropathogenic and enterohaemorrhagic Escherichia coli during ex vivo colonization of human intestinal mucosa is different to cell culture models. Cell Microbiol. 2007;9:1352–1364. [PubMed]A important study which identifies that effector function using cell lines is different to that which likely occurs in vivo. Specifically, it reveals that Tir tyrosine phosphorylation which is essential for pedestal formation in cell culture models, is not important within in vivo differentiated epithelia. This cautions on the need to use or at least verify new finding in the most appropriate models.
31. Alto N.M., Shao F., Lazar C.S., Brost R.L., Chua G., Mattoo S., McMahon S.A., Ghosh P., Hughes T.R., Boone C. Identification of a bacterial type III effector family with G protein mimicry functions. Cell. 2006;124:133–145. [PubMed]
32. Kenny B., Ellis S., Leard A.D., Warawa J., Mellor H., Jepson M.A. Co-ordinate regulation of distinct host cell signalling pathways by multifunctional enteropathogenic Escherichia coli effector molecules. Mol Microbiol. 2002;44:1095–1107. [PubMed]
33. Simpson N., Shaw R., Crepin V.F., Mundy R., FitzGerald A.J., Cummings N., Straatman-Iwanowska A., Connerton I., Knutton S., Frankel G. The enteropathogenic Escherichia coli type III secretion system effector Map binds EBP50/NHERF1: implication for cell signalling and diarrhoea. Mol Microbiol. 2006;60:349–363. [PubMed]
34••. Hume P.J., Koronakis V. Mimicry is the sincerest form of flattery? Cell Host Microbe. 2008;4:411–412. [PubMed]An excellent and concise review article that puts forward a robust and convincing argument to suggest that the WxxxE containing effectors may not be mimics of small GTPase and that the WxxxE motif itself may be structural rather than forming part of an active GTPase domain.
35. Papatheodorou P., Domanska G., Oxle M., Mathieu J., Selchow O., Kenny B., Rassow J. The enteropathogenic Escherichia coli (EPEC) Map effector is imported into the mitochondrial matrix by the TOM/Hsp70 system and alters organelle morphology. Cell Microbiol. 2006;8:677–689. [PubMed]
36•. Kim J., Thanabalasuriar A., Chaworth-Musters T., Fromme J.C., Frey E.A., Lario P.I., Metalnikov P., Rizg K., Thomas N.A., Lee S.F. The bacterial virulence factor NleA inhibits cellular protein secretion by disrupting mammalian COPII function. Cell Host Microbe. 2007;2:160–171. [PubMed]The first comprehensive and detailed study into the cellular function of a non-LEE effector, NleA and the first EPEC effector shown to inhibit protein secretion. The authors go to great lengths to characterise NleA function and reveal the protein binding partners and a molecular mechanism to explain the inhibition of protein secretion.
37. Marches O., Covarelli V., Dahan S., Cougoule C., Bhatta P., Frankel G., Caron E. EspJ of enteropathogenic and enterohaemorrhagic Escherichia coli inhibits opsono-phagocytosis. Cell Microbiol. 2008;10:1104–1115. [PMC free article] [PubMed]
38. Zurawski D.V., Mumy K.L., Badea L., Prentice J.A., Hartland E.L., McCormick B.A., Maurelli A.T. The NleE/OspZ family of effector proteins is required for polymorphonuclear transepithelial migration, a characteristic shared by enteropathogenic Escherichia coli and Shigella flexneri infections. Infect Immun. 2008;76:369–379. [PMC free article] [PubMed]
39. Hemrajani C., Marches O., Wiles S., Girard F., Dennis A., Dziva F., Best A., Phillips A.D., Berger C.N., Mousnier A. Role of NleH, a type III secreted effector from attaching and effacing pathogens, in colonization of the bovine, ovine, and murine gut. Infect Immun. 2008;76:4804–4813. [PMC free article] [PubMed]
40. Garcia-Angulo V.A., Deng W., Thomas N.A., Finlay B.B., Puente J.L. Regulation of expression and secretion of NleH, a new non-locus of enterocyte effacement-encoded effector in Citrobacter rodentium. J Bacteriol. 2008;190:2388–2399. [PMC free article] [PubMed]
41. Kelly M., Hart E., Mundy R., Marches O., Wiles S., Badea L., Luck S., Tauschek M., Frankel G., Robins-Browne R.M. Essential role of the type III secretion system effector NleB in colonization of mice by Citrobacter rodentium. Infect Immun. 2006;74:2328–2337. [PMC free article] [PubMed]
42. Dahan S., Wiles S., La Ragione R.M., Best A., Woodward M.J., Stevens M.P., Shaw R.K., Chong Y., Knutton S., Phillips A. EspJ is a prophage-carried type III effector protein of attaching and effacing pathogens that modulates infection dynamics. Infect Immun. 2005;73:679–686. [PMC free article] [PubMed]
43. Echtenkamp F., Deng W., Wickham M.E., Vazquez A., Puente J.L., Thanabalasuriar A., Gruenheid S., Finlay B.B., Hardwidge P.R. Characterization of the NleF effector protein from attaching and effacing bacterial pathogens. FEMS Microbiol Lett. 2008;281:98–107. [PMC free article] [PubMed]
44. Gruenheid S., Sekirov I., Thomas N.A., Deng W., O’Donnell P., Goode D., Li Y., Frey E.A., Brown N.F., Metalnikov P. Identification and characterization of NleA, a non-LEE-encoded type III translocated virulence factor of enterohaemorrhagic Escherichia coli O157:H7. Mol Microbiol. 2004;51:1233–1249. [PubMed]
45•. Ruchaud-Sparagano M.H., Maresca M., Kenny B. Enteropathogenic Escherichia coli (EPEC) inactivate innate immune responses prior to compromising epithelial barrier function. Cell Microbiol. 2007;9:1909–1921. [PMC free article] [PubMed]This paper provides a plausible explanation about why EPEC infection is linked with a weak inflammatory response. EPEC was shown to inhibit innate immune responses (IKK, MAP kinase and PI-3 kinase pathways) through unidentified effector(s). Crucially, this inhibition occurred before tight junctions were disrupted, preventing elicitors such as flagellin stimulating inflammatory responses in the basolateral domain.
46. Vallance B.A., Deng W., Knodler L.A., Finlay B.B. Mice lacking T and B lymphocytes develop transient colitis and crypt hyperplasia yet suffer impaired bacterial clearance during Citrobacter rodentium infection. Infect Immun. 2002;70:2070–2081. [PMC free article] [PubMed]
47. Sharma R., Tesfay S., Tomson F.L., Kanteti R.P., Viswanathan V.K., Hecht G. Balance of bacterial pro- and anti-inflammatory mediators dictates net effect of enteropathogenic Escherichia coli on intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol. 2006;290:G685–G694. [PubMed]
48. Loukiadis E., Nobe R., Herold S., Tramuta C., Ogura Y., Ooka T., Morabito S., Kerouredan M., Brugere H., Schmidt H. Distribution, functional expression, and genetic organization of Cif, a phage-encoded type III-secreted effector from enteropathogenic and enterohemorrhagic Escherichia coli. J Bacteriol. 2008;190:275–285. [PMC free article] [PubMed]
49. Hardwidge P.R., Donohoe S., Aebersold R., Finlay B.B. Proteomic analysis of the binding partners to enteropathogenic Escherichia coli virulence proteins expressed in Saccharomyces cerevisiae. Proteomics. 2006;6:2174–2179. [PubMed]
50. Lee S.F., Kelly M., McAlister A., Luck S.N., Garcia E.L., Hall R.A., Robins-Browne R.M., Frankel G., Hartland E.L. A C-terminal class I PDZ binding motif of EspI/NleA modulates the virulence of attaching and effacing Escherichia coli and Citrobacter rodentium. Cell Microbiol. 2008;10:499–513. [PubMed]
51. Nougayrede J.P., Foster G.H., Donnenberg M.S. Enteropathogenic Escherichia coli effector EspF interacts with host protein Abcf2. Cell Microbiol. 2007;9:680–693. [PubMed]
52. Peralta-Ramirez J., Hernandez J.M., Manning-Cela R., Luna-Munoz J., Garcia-Tovar C., Nougayrede J.P., Oswald E., Navarro-Garcia F. EspF interacts with nucleation-promoting factors to recruit junctional proteins into pedestals for pedestal maturation and disruption of paracellular permeability. Infect Immun. 2008;76:3854–3868. [PMC free article] [PubMed]
53. Hodges K., Alto N.M., Ramaswamy K., Dudeja P.K., Hecht G. The enteropathogenic Escherichia coli effector protein EspF decreases sodium hydrogen exchanger 3 activity. Cell Microbiol. 2008;10:1735–1745. [PMC free article] [PubMed]